Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and is the most common cause of infertility due to anovulation. There is no single criterion for the diagnosis of this syndrome. Objective: The purpose of this study was to investigate the prevalence of PCOS and its associated complications in Iranian women using meta-analysis method. Materials and Methods: Prevalence of PCOS was investigated from the SID, Goggle scholar, PubMed, Magiran, Irandoc, and Iranmedex, and weighting of each study was calculated according to sample size and prevalence of the binomial distribution. Data were analyzed using a random-effects model meta-analysis (Random effects model) and the software R and Stata Version 11.2. Results: 30 studies conducted between the years 2006 to 2011 were entered into meta-analysis. The total sample size was 19, 226 women aged between 10-45 years. The prevalence of PCOS based on National institute of child health and human disease of the U.S was, 6.8% (95 % CI: 4.11–8.5), based on Rotterdam was 19.5% (95 % CI: 2.24-8.14), and based on ultrasound was 4.41% (95% CI: 5.68-4.14). Also, the prevalence of hirsutism was estimated to be 13%, acne 26%, androgenic alopecia 9%, menstrual disorders 28%, overweight 21%, obesity 19%, and infertility 8%. Conclusion: The prevalence of PCOS in Iran is not high. However, given the risk of complications such as heart disease - cardiovascular and infertility, prevention of PCOS is important; we suggest that health officials must submit plans for the community in this respect.

[1]  S. Zandi,et al.  Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings , 2016 .

[2]  C. Pate.  Issues Faced by Women With Hirsutism: State of the Science , 2016, Health care for women international.

[3]  Shashikant Malkud.  A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. , 2015, Journal of clinical and diagnostic research : JCDR.

[4]  Z. Emami,et al.  INCREASED PREVALENCE OF DEPRESSION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME , 2012 .

[5]  F. Azizi,et al.  The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study , 2011, Reproductive biology and endocrinology : RB&E.

[6]  Akbarzadeh Marzieh,et al.  FREQUENCY OF FACIAL AND BODY ACNE IN 14- TO 18- YEAR-OLD FEMALE HIGH SCHOOL STUDENTS AND ITS RELATIONSHIP TO POLYCYSTIC OVARY SYNDROME , 2011 .

[7]  F. Azizi,et al.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study , 2011, Reproductive biology and endocrinology : RB&E.

[8]  M. Asgharnia,et al.  The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria , 2011, International journal of fertility & sterility.

[9]  H. Shirvani,et al.  EVALUATION OF THE PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT (15-18 YEARS OLD) GIRLS IN TEHRAN DURING 2005-2006 , 2010 .

[10]  N. Ghasemi,et al.  FREQUENCY OF POLY CYSTIC OVARY SYNDROME IN PATIENTS WITH PREMENOPAUSAL BREAST CANCER , 2010 .

[11]  M. T. Noorbala,et al.  THE PREVALENCE OF HIRSUTISM IN ADOLESCENT GIRLS IN YAZD, CENTRAL IRAN , 2010 .

[12]  R. Norman,et al.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.

[13]  S. Fekri,et al.  The Prevalence of Polycystic Ovarian Syndrome in 14-18 year old girls of Zanjan High Schools, 2008 , 2009 .

[14]  T. Alenabi,et al.  The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes , 2009, Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT.

[15]  A. Kamkhah,et al.  HORMONAL PROFILE IN HIRSUTE PATIENTS REFERRED TO A LABORATORY IN SHAHREKORD, 2005 , 2009 .

[16]  C. Wijeyaratne,et al.  A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. , 2008, American journal of epidemiology.

[17]  M. Kashanian,et al.  Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome. , 2008, Diabetes research and clinical practice.

[18]  M. Amini,et al.  THE PREVALENCE OF POLYCYSTIC OVARY SYNDROME (PCOS) IN TYPE 2 DIABETIC WOMEN IN REPRODUTIVE AGES , 2006 .

[19]  G. Kovacs,et al.  Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[20]  M. Hashemipour,et al.  Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran , 2004, Hormone Research in Paediatrics.

[21]  S. Jahanfar,et al.  Leptin and its association with polycystic ovary syndrome: a twin study , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[22]  F. Stanczyk,et al.  The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. , 2004, American journal of obstetrics and gynecology.

[23]  C. Glueck,et al.  Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. , 2002, Fertility and sterility.

[24]  D. Cibula,et al.  The role of androgens in determining acne severity in adult women , 2000, The British journal of dermatology.

[25]  D. Dunger,et al.  Polycystic ovaries and associated clinical and biochemical features in young women , 1999, Clinical endocrinology.

[26]  E. Diamanti-Kandarakis,et al.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.

[27]  R. Hirasing,et al.  Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. , 1999, Human reproduction.

[28]  R. Marks,et al.  The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris , 1998, The British journal of dermatology.

[29]  E. Baracat,et al.  Polycystic ovary syndrome: clinical and laboratory evaluation. , 1996, Sao Paulo medical journal = Revista paulista de medicina.

[30]  I. Salama,et al.  Hirsutism in the United Arab Emirates: a hospital study. , 1996, Postgraduate medical journal.

[31]  C. Farquhar,et al.  The Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women , 1994, The Australian & New Zealand journal of obstetrics & gynaecology.

[32]  R. Lobo.  Hirsutism in Polycystic Ovary Syndrome: Current Concepts , 1991, Clinical obstetrics and gynecology.

[33]  C. Bunker,et al.  Most women with acne have polycystic ovaries , 1989, The British journal of dermatology.

[34]  C. Bunker,et al.  The prevalence of polycystic ovaries in patients with acne vulgaris , 1988 .

[35]  Josephine Barnes.  Royal Medical Benevolent Fund Christmas appeal , 1986 .

[36]  S. Franks,et al.  Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. , 1986, British medical journal.

[37]  E. Mcknight.  THE PREVALENCE OF "HIRSUTISM" IN YOUNG WOMEN. , 1964, Lancet.

[38]  R. Kelishadi,et al.  The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. , 2011, Endokrynologia Polska.

[39]  R. Heshmat,et al.  The prevalence of polycystic ovary syndrome in Iranian women with gestational diabetes: a pilot study , 2009 .

[40]  Razieh Soltani-Arabshahi,et al.  Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women. , 2007, Archives of Iranian medicine.

[41]  M. Lankarani,et al.  COMPARISON OF EFFECTIVENESS OF LOVASTATIN AND GEMFIBROZIL ON HDL-C LEVEL IN DIABETIC TYPE 2 PATIENTS , 2005 .

[42]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[43]  D. Rushton,et al.  Management of hair loss in women. , 1993, Dermatologic clinics.

[44]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .